1. Home
  2. ASRT vs OPRX Comparison

ASRT vs OPRX Comparison

Compare ASRT & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
    SELLHOLDBUYas of a day ago
  • OPRX
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • ASRT 1995
  • OPRX 2006
  • Country
  • ASRT United States
  • OPRX United States
  • Employees
  • ASRT N/A
  • OPRX N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • OPRX Business Services
  • Sector
  • ASRT Health Care
  • OPRX Consumer Discretionary
  • Exchange
  • ASRT Nasdaq
  • OPRX Nasdaq
  • Market Cap
  • ASRT 78.3M
  • OPRX 84.4M
  • IPO Year
  • ASRT 1997
  • OPRX N/A
  • Fundamental
  • Price
  • ASRT $0.67
  • OPRX $8.33
  • Analyst Decision
  • ASRT Strong Buy
  • OPRX Buy
  • Analyst Count
  • ASRT 3
  • OPRX 8
  • Target Price
  • ASRT $3.08
  • OPRX $9.06
  • AVG Volume (30 Days)
  • ASRT 412.7K
  • OPRX 1.3M
  • Earning Date
  • ASRT 05-05-2025
  • OPRX 05-13-2025
  • Dividend Yield
  • ASRT N/A
  • OPRX N/A
  • EPS Growth
  • ASRT N/A
  • OPRX N/A
  • EPS
  • ASRT N/A
  • OPRX N/A
  • Revenue
  • ASRT $124,961,000.00
  • OPRX $92,127,000.00
  • Revenue This Year
  • ASRT N/A
  • OPRX $12.12
  • Revenue Next Year
  • ASRT $11.20
  • OPRX $10.87
  • P/E Ratio
  • ASRT N/A
  • OPRX N/A
  • Revenue Growth
  • ASRT N/A
  • OPRX 28.81
  • 52 Week Low
  • ASRT $0.65
  • OPRX $3.78
  • 52 Week High
  • ASRT $1.80
  • OPRX $14.13
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 35.44
  • OPRX 59.40
  • Support Level
  • ASRT $0.70
  • OPRX $7.98
  • Resistance Level
  • ASRT $0.80
  • OPRX $8.94
  • Average True Range (ATR)
  • ASRT 0.05
  • OPRX 0.83
  • MACD
  • ASRT -0.00
  • OPRX -0.04
  • Stochastic Oscillator
  • ASRT 15.22
  • OPRX 49.67

Stock Price Comparison Chart: ASRT vs OPRX

ASRT
OPRX
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100ASRT VS OPRX

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use